Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents

Abstract

These findings demonstrate that signaling through JNK is a determinant of response to therapy in colon cancer models, and support the testing of JNK inhibition to sensitize colon tumors in the clinic.